Financial Architects, Inc Amgen Inc Transaction History

Financial Architects, Inc

$657 Million
Q2 2023

A detailed history of Financial Architects, Inc transactions in Amgen Inc stock. As of the latest transaction made, Financial Architects, Inc holds 2,683 shares of AMGN stock, worth $800,177. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,683

Previous 2,683 -0.0%

Holding current value

$800,177

Previous $648,000 8.18%

% of portfolio

0.09%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $37,481 - $45,683	-166 Reduced 5.83%	2,683 $648,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $20,154 - $25,608	88 Added 3.19%	2,849 $748,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $20,874 - $23,542	93 Added 3.49%	2,761 $622,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $17,995 - $20,025	78 Added 3.01%	2,668 $649,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $10,963 - $12,128	-50 Reduced 1.89%	2,590 $626,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $29,717 - $34,818	140 Added 5.6%	2,640 $561,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $8,642 - $9,588	-37 Reduced 1.46%	2,500 $609,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $66,794 - $77,838	301 Added 13.46%	2,537 $631,000
Q4 2020 Feb 17, 2021	BUY	$216.38 - $257.67 $2,812 - $3,349	13 Added 0.58%	2,236 $514,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $6,923 - $8,495	35 Added 1.6%	2,223 $524,000
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $2,733 - $3,625	-15 Reduced 0.68%	2,188 $444,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $7,189 - $9,241	38 Added 1.76%	2,203 $531,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $6,093 - $7,301	-35 Reduced 1.59%	2,165 $419,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $251,050 - $294,287	1,506 Added 217.0%	2,200 $405,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $125,523 - $141,492	694 New	694 $132,000
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $120,821 - $136,191	-668 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $356 - $416	2 Added 0.3%	668 $130,000
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $10,932 - $12,324	59 Added 9.72%	666 $138,000
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $5,977 - $6,714	-36 Reduced 5.6%	607 $112,000
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $237,371 - $277,398	-1,401 Reduced 68.54%	643 $110,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $236,643 - $264,403	-1,402 Reduced 40.68%	2,044 $355,000
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $564,771 - $644,816	3,376 Added 4822.86%	3,446 $642,000
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $11,710 - $13,370	70	70 $13,000

Others Institutions Holding AMGN

# of Institutions

3,312

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $160B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Account

Financial Architects, Inc Amgen Inc Transaction History